FDA Drug recall D-0737-2022
Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Man…
- FDA Drug
- Class II
- terminated
- Published 2022-04-06
On 2022-04-06 the FDA classified a Class II recall of Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Man… by Dr Reddy S Laboratories, citing failed Dissolution Specifications; during long term stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0737-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-03-23 |
| Published | 2022-04-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India
Reason
Failed Dissolution Specifications; during long term stability testing.
Identifiers
| ndc | 55111-398-30 |
|---|---|
| ndc | 55111-398-60 |
| ndc | 55111-398-90 |
| ndc | 55111-398-01 |
| ndc | 55111-398-05 |
| ndc | 55111-398-79 |
| ndc | 55111-399-30 |
| ndc | 55111-399-60 |
| ndc | 55111-399-90 |
| ndc | 55111-399-01 |
| ndc | 55111-399-05 |
| ndc | 55111-399-79 |
| code_info | Lot # a) C2103093, Exp. 12/2023; b)C2103092, Exp. 12/2023. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0737-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.